// App-Quantinova.ai

P1733 : NON-HEMATOLOGICAL MALIGNANCIES IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE PATIENTS: A MATCHED COHORT ANALYSIS USING A HEALTH CLAIMS-BASED DATASET

Researchers

Presenter

  • Sudipto Mukherjee

Principal Investigators

  • Karan Kanhai

  • Rabecka Martin

  • Jeremy Paige

  • Anirvan Ghosh

  • Francis Shupo

  • David Fajgenbaum

Medical Centers

  • Department of Hematology and Medical Oncology,Taussig Cancer

  • EUSA Pharma,Hemel Hempstead,Storbritannien

  • EVERSANA,Milwaukee,Vereinigte Staaten

  • EUSA Pharma,Hemel Hempstead,Royaume-uni

  • Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

  • Department of Medicine,Perelman School of Medicine, University of Pennsylvania,Philadelphia,Vereinigte Staaten

  • EUSA Pharma, Hemel Hempsted, United Kingdom

  • EUSA Pharma,Burlington,États-unis

  • EVERSANA,Milwaukee,Vereinigte Staaten

  • EVERSANA,Milwaukee,United States

  • EUSA Pharma,Hemel Hempstead,Reino Unido

  • EVERSANA,Milwaukee,États-unis

  • EUSA Pharma,Burlington,USA

  • Department of Medicine,Perelman School of Medicine, University of Pennsylvania,Philadelphia,Vereinigte Staaten

  • EUSA Pharma,Hemel Hempstead,Verenigd Koninkrijk

  • EUSA Pharma,Hemel Hempstead,Vereinigtes Königreich

  • Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania

  • EVERSANA,Milwaukee,Stati Uniti

  • EUSA Pharma,Burlington,Verenigde Staten

  • EVERSANA,Milwaukee,USA

  • EUSA Pharma,Burlington,Stati Uniti

  • EUSA Pharma,Hemel Hempstead,Соединённое Королевство

  • EUSA Pharma,Burlington,United States

  • EUSA Pharma,Burlington,Verenigde Staten

  • EUSA Pharma,Hemel Hempstead,Reino Unido

  • Department of Medicine,Perelman School of Medicine, University of Pennsylvania,Philadelphia,Vereinigte Staaten

  • Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

  • EUSA Pharma,Burlington,Estados Unidos

  • EVERSANA,Milwaukee,Estados Unidos

  • Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Autoimmune (AI)

  • Oncology (ONC)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Solid malignancies

  • Hematological malignancies

  • Castleman disease

  • Thyroid Cancer

  • Idiopathic multicentric Castleman’ s disease

Biomarkers

  • N/A

Drug/Treatment

  • ILS-969

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved